描述
Comparative analysis of probiotic-fermented versus unfermented herbal preparations for metabolic endpoints. Head-to-head efficacy data from preclinical and clinical studies quantify the synergistic benefits of combined approaches.
Figure 22
DiagramSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 22: Comparative analysis of probiotic-fermented versus unfermented herbal preparations for metabolic endpoints. Head-to-head efficacy data from preclinical and clinical studies quantify the synergistic benefits of combined approaches.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Comparative analysis of probiotic-fermented versus unfermented herbal preparations for metabolic endpoints. Head-to-head efficacy data from preclinical and clinical studies quantify the synergistic benefits of combined approaches." /> <figcaption>Figure 22. Comparative analysis of probiotic-fermented versus unfermented herbal preparations for metabolic endpoints. Head-to-head efficacy data from preclinical and clinical studies quantify the synergistic benefits of combined approaches.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>